Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Technology Innovation Institute (TII) is a leading global research center based in Abu Dhabi, United Arab Emirates, and serves as the applied research pillar of the Advanced Technology Research Council (ATRC). Its Biotechnology Research Center (BRC) focuses on advancing precision medicine, synthetic biology, and next-generation therapeutics through high-throughput screening and genomic analysis. TII operates as a bridge between academic discovery and commercial application, developing innovative solutions for infectious diseases, oncology, and rare genetic disorders. The institute leverages advanced computational biology and AI-driven drug discovery to accelerate the development of novel modalities, including gene therapies and vaccines. With state-of-the-art laboratories and a global network of collaborators, TII is a central hub for life science innovation in the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technology Innovation Investment.